heather, Author at Applied DNA Sciences

Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of APDN’s Linea DNA™ for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML

STONY BROOK, N.Y., and PRAGUE, Czechia - May 13, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, and the Institute of Hematology and Blood Transfusion (ÚHKT/IHBT) today announced that an abstract relating to the development of a fully enzymatic, non-viral manufacturing workflow to enable the rapid [...]

heather2024-05-13T11:37:58-04:00Categories: Linear DNA, Press Release|Tags: Hematology, Institute of Hematology and Blood Transfusion, James A Hayward|

APDN Announces Second Quarter Fiscal Year 2024 Financial Results

STONY BROOK, N.Y. May 10, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced consolidated financial results for its second fiscal quarter ended March 31, 2024. The Company’s Form 10-Q can be viewed at https://investors.adnas.com/sec-filings/. The Company will not host a financial [...]

heather2024-09-23T11:36:28-04:00Categories: Investors, Press Release|

CertainT Market Insight 2023-2024 Report: Xinjiang Cotton Circumventing UFLPA

The “CertainT® Market Insight 2023-2024 Report: Xinjiang Cotton Circumventing UFLPA” provides the findings of a market study conducted between February 2023 through March 2024 that reveal 19% of all samples tested showed evidence of Xinjiang cotton. The report was prepared independently by Applied DNA Sciences and Stratum Reservoir. Key findings from the CertainT Report reveal [...]

heather2024-05-13T11:00:16-04:00Categories: APDN in the News, CertainT®, Cotton, Textile and Apparel|Tags: Stratum Reservoir, UFLPA, Xinjiang|

APDN Regains Compliance with Nasdaq Minimum Bid Price Requirement

STONY BROOK, N.Y., - May 10, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on May 9, 2024, it received a notification letter (the “Notification Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”), informing the Company that it has regained [...]

heather2024-05-09T18:43:06-04:00Categories: Investors, Press Release|

Tests highlight Xinjiang cotton concerns

STONY BROOK - CHAMPAIGN - DNA and isotopic testing has revealed that 19% of all textile-based products tested contained cotton from the Xinjiang region of China which is banned in the US over forced labour concerns. Molecular technologies specialist Applied DNA Sciences (ADNAS) and Isotech Laboratories, part of the Stratum Reservoir group, tested 822 [...]

heather2024-05-13T14:39:58-04:00Categories: APDN in the News, CertainT®, Cotton, Textile and Apparel|

Banned Chinese cotton found in 19% of US and global retailers’ merchandise, study shows

NEW YORK, May 7 (Reuters) – Traces of banned Chinese cotton were found in 19% of a sample of merchandise selling at U.S. and global retailers in the past year, a study showed, highlighting the challenges of complying with the U.S. law aimed at blocking imports of cotton linked to forced labor in China. [...]

heather2024-05-08T10:25:24-04:00Categories: APDN in the News, CertainT®, Cotton, Textile and Apparel|Tags: Cotton, Reuters, UFLPA, Xinjiang|

APDN Awarded Contract by HDT Bio For Rapid Vaccine Development Program

STONY BROOK, N.Y., April 25, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced the award of a contract from HDT Bio for the purpose of rapid, next-generation vaccine development under a ‘Project NextGen: Enabler’ award to HDT Bio (the “Project”). The Project seeks [...]

heather2024-04-25T09:01:06-04:00Categories: Linear DNA, Press Release, Vaccines|Tags: HDT Bio, Vaccines|

Applied DNA Announces 1-For-20 Reverse Stock Split

STONY BROOK, N.Y. – April 22, 2024 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the Company), a leader in PCR-based DNA technologies, today announced that it will effect a 1-for-20 stock split of its common stock, to be effective as of 12:01 a.m. Eastern Time on Thursday, April 25, 2024. Applied DNA common stock [...]

heather2024-05-13T15:08:36-04:00Categories: Investors, Press Release|

Applied DNA, Alphazyme Agreement for Scale-Up Linea™ RNAP

STONY BROOK, N.Y., and JUPITER, F.L. March 18, 2024 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the Company), a leader in PCR-based DNA technologies, and Alphazyme LLC (Alphazyme), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of specialty enzymes used in the life sciences sector, have entered into an agreement under which [...]

heather2024-05-13T15:08:58-04:00Categories: Linear DNA, Press Release|Tags: Alphazyme, James A Hayward, Maravai, RNAP|

About heather